Tessera
Folgen

CLARITY_Initiative

@clarityinitiative.bsky.social

https://clarityinitiative.org/

5 Posts18 Follower9 Folgt
Angela Huttner @angelahuttner.bsky.social · 2mo ago

Happy to be part of this free online series introducing the use of statistics within clinical trials, conceived and developed by the superstars of ADVANCE-ID #IDSky #MedSky #EpiSky

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)@advance-id.bsky.social · 2mo ago

Demystify clinical trial design & enhance your research toolkit!📊✨ Join our statistical seminars supported by @advance-id.bsky.social & @who.int Explore clinical trial theory & real-life examples with global experts. Master the numbers in the mission against disease here: ad-id.co/stats

CMI Communications@cmicomms.bsky.social · 11mo ago

📣 We're thrilled to be part of #CLARITY, an initiative led by Josh Davis @gurujosh.bsky.social & @steventong.bsky.social for physicians, pharmacists & #clinmicro specialists passionate about #clinicalresearch & #evidence appraisal. Join us! 🌱 #IDSky #MedSky #MedEd www.cmi-comms.org/article/S295...

The CLARITY initiative: Clinical Literature Appraisal and Research education in InfecTious diseases and microbiologY

Over the past two decades, the generation and application of clinical evidence in the fields of clinical infectious diseases and microbiology have entered a new era: one in which clinical guidelines a...

cmi-comms.org

Steven Tong@steventong.bsky.social · 5mo ago

ESCMID 2026 highlights Dalbavancin PK (DOTS‑PK) – Two doses may not be enough High protein binding and wide inter‑patient variability: 1/3 patients may be sub‑therapeutic by day 22 Bottom line: Consider monitoring levels or adding a third dose in complex infections clarityinitiative.org/home

Clarity Initiative

Clarity Initiative offers clinical literature appraisal and research education in infectious diseases, enhancing knowledge through courses and resources.

clarityinitiative.org